An Observational Study to Develop a Predictive Model for Bacterial Pneumonia Diagnosis in Severe COVID-19 Patients-C19-PNEUMOSCORE.
COVID-19
antimicrobial stewardship
bacterial co-infection
bacterial pneumonia
prognostic tool
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
14 Jul 2023
14 Jul 2023
Historique:
received:
18
06
2023
revised:
11
07
2023
accepted:
12
07
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
In COVID-19 patients, antibiotics overuse is still an issue. A predictive scoring model for the diagnosis of bacterial pneumonia at intensive care unit (ICU) admission would be a useful stewardship tool. We performed a multicenter observational study including 331 COVID-19 patients requiring invasive mechanical ventilation at ICU admission; 179 patients with bacterial pneumonia; and 152 displaying negative lower-respiratory samplings. A multivariable logistic regression model was built to identify predictors of pulmonary co-infections, and a composite risk score was developed using β-coefficients. We identified seven variables as predictors of bacterial pneumonia: vaccination status (OR 7.01; 95% CI, 1.73-28.39); chronic kidney disease (OR 3.16; 95% CI, 1.15-8.71); pre-ICU hospital length of stay ≥ 5 days (OR 1.94; 95% CI, 1.11-3.4); neutrophils ≥ 9.41 × 10
Identifiants
pubmed: 37510807
pii: jcm12144688
doi: 10.3390/jcm12144688
pmc: PMC10381000
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Ministero della Salute
ID : GR-2018-1236737
Références
Clin Infect Dis. 2021 May 18;72(10):e533-e541
pubmed: 32820807
Crit Care. 2022 May 9;26(1):130
pubmed: 35534867
Diagn Microbiol Infect Dis. 2022 Jan;102(1):115558
pubmed: 34731685
Clin Respir J. 2021 Jul;15(7):815-825
pubmed: 33818909
Lancet Respir Med. 2020 Dec;8(12):1201-1208
pubmed: 32861276
Infection. 2023 Feb;51(1):129-136
pubmed: 35687293
Blood. 2022 Jul 21;140(3):236-252
pubmed: 35544585
Infection. 2022 Oct;50(5):1243-1253
pubmed: 35488112
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
J Infect. 2022 Oct;85(4):374-381
pubmed: 35781017
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399
pubmed: 32603803
Intensive Care Med. 2020 Sep;46(9):1787-1789
pubmed: 32661615
Am J Respir Crit Care Med. 2021 Sep 1;204(5):546-556
pubmed: 34038699
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Ann Intensive Care. 2020 Sep 7;10(1):119
pubmed: 32894364
Microbiol Spectr. 2021 Dec 22;9(3):e0069521
pubmed: 34756067
JAC Antimicrob Resist. 2021 Nov 28;3(4):dlab180
pubmed: 34859223
Chest. 2021 Aug;160(2):454-465
pubmed: 33857475
J Med Virol. 2021 Jul;93(7):4564-4569
pubmed: 33822390
Crit Care. 2021 Jun 7;25(1):197
pubmed: 34099016
Clin Infect Dis. 2020 Nov 19;71(16):2174-2179
pubmed: 32445579
Clin Microbiol Infect. 2023 Jun;29(6):734-743
pubmed: 36681325
Lancet Infect Dis. 2022 Sep;22(9):1293-1302
pubmed: 35753318
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Antibiotics (Basel). 2022 Jul 04;11(7):
pubmed: 35884147
J Clin Med. 2022 Dec 04;11(23):
pubmed: 36498781
J Microbiol Immunol Infect. 2022 Dec;55(6 Pt 1):985-992
pubmed: 36243668
Toxins (Basel). 2020 May 06;12(5):
pubmed: 32384617
JAMA Netw Open. 2022 Oct 3;5(10):e2238871
pubmed: 36301541
Clin Infect Dis. 2021 Jan 22;:
pubmed: 33480973
Intensive Care Med. 2021 Jan;47(1):104-106
pubmed: 33068116
Front Public Health. 2022 Sep 12;10:963667
pubmed: 36172213
Clin Microbiol Infect. 2021 Jan;27(1):83-88
pubmed: 32745596
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
Curr Opin Crit Care. 2018 Oct;24(5):339-346
pubmed: 30028740
Intensive Care Med. 2022 Jun;48(6):690-705
pubmed: 35596752
Int J Antimicrob Agents. 2021 Oct;58(4):106409
pubmed: 34339777
Int J Infect Dis. 2020 Jul;96:291-293
pubmed: 32437939
Curr Opin Pulm Med. 2012 May;18(3):213-21
pubmed: 22388582